--- title: "European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/286794388.md" description: "European equities traded in the US as American depositary receipts rose 0.88% to 1,825.10 on the S&P Europe Select ADR Index. Notable gainers included Evaxion (+4.6%) and Royal Philips (+2.9%), while decliners included DBV Technologies (-3.2%) and BioNTech (-2%). UK gainers were led by Autolus Therapeutics (+16%) and Trinity Biotech (+6.2%), with NuCana (-8.3%) and Biodexa Pharmaceuticals (-3%) among the decliners." datetime: "2026-05-18T15:11:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286794388.md) - [en](https://longbridge.com/en/news/286794388.md) - [zh-HK](https://longbridge.com/zh-HK/news/286794388.md) --- # European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading 11:11 AM EDT, 05/18/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were heading higher late Monday morning, rising 0.88% to 1,825.10 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and healthcare tech company Royal Philips (PHG), which rose 4.6% and 2.9% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biopharmaceutical company Grifols ( GRFS ) , which were up 2.8% each. The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm BioNTech (BNTX), which dropped 3.2% and 2% respectively. They were followed by telecommunications company Nokia ( NOK ) and pharmaceutical company Ascendis Pharma ( ASND ) , which were down 1.9% and 0.9% respectively. The gainers from the UK were led by biotech companies Autolus Therapeutics ( AUTL ) and Trinity Biotech ( TRIB ) , which climbed 16% and 6.2% respectively. They were followed by communications company WPP ( WPP ) and educational publisher Pearson (PSO), which advanced 4.8% and 4.7% respectively. The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which fell 8.3% and 3% respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and Mereo BioPharma Group ( MREO ) , which were off 2.1% and 1% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### Related Stocks - [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md) - [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md) - [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md) - [TRIB.US](https://longbridge.com/en/quote/TRIB.US.md) - [PHG.US](https://longbridge.com/en/quote/PHG.US.md) - [CRTO.US](https://longbridge.com/en/quote/CRTO.US.md) - [GRFS.US](https://longbridge.com/en/quote/GRFS.US.md) - [NOK.US](https://longbridge.com/en/quote/NOK.US.md) - [ASND.US](https://longbridge.com/en/quote/ASND.US.md) - [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md) - [WPP.US](https://longbridge.com/en/quote/WPP.US.md) - [WPP.UK](https://longbridge.com/en/quote/WPP.UK.md) - [PSO.US](https://longbridge.com/en/quote/PSO.US.md) - [PSON.UK](https://longbridge.com/en/quote/PSON.UK.md) - [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md) - [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md) - [AMRN.US](https://longbridge.com/en/quote/AMRN.US.md) - [MREO.US](https://longbridge.com/en/quote/MREO.US.md) - [RYLPF.US](https://longbridge.com/en/quote/RYLPF.US.md) - [NOA3.DE](https://longbridge.com/en/quote/NOA3.DE.md) ## Related News & Research - [BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM](https://longbridge.com/en/news/286592399.md) - [Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC](https://longbridge.com/en/news/286169551.md) - [Germany says vaccine supply secure despite BioNTech production loss](https://longbridge.com/en/news/285369696.md) - [Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock](https://longbridge.com/en/news/283899032.md) - [BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides](https://longbridge.com/en/news/285397427.md)